NEW WAYS vergibt European Advanced SDG Award an 50 Unternehmen

Wien (OTS) - NEW WAYS Center for Sustainable Development ehrte am Montag, den 24. August 2020, 50 europäische Unternehmen mit dem European Advanced SDG Award - Exzellenz in der Umsetzung der UN SDGs in der Diplomatischen Akademie Wien. Preisträger waren u.a. die Luxembourg Green Exchange/LUX, als erste Börse der Welt, welche ausschließlich nachhaltige Wertpapiere listet, nämlich mehr als 780; Pipistrel,/SLO - das weltweit erste Elektroflugzeug; das Black Sea Universities Network/RO; das River Clleaning Project/IT -

Paradise Art Space präsentiert die Ausstellung Prism Fantasy: New ways to view light

Incheon, Südkorea (ots/PRNewswire) - Reflexion, Unendlichkeit, Spektrum und Illusion stehen im Zentrum der Betrachtungen elf weltbekannter Installationskünstler Umfangreiche Gemeinschaftsausstellung von Weltklasse-Künstlern, die vom 19. April bis 18. August zu sehen ist 25 Werke, darunter Plexus No.40 von Gabriel Dawe, werden in der Ausstellung gezeigt Vier wesentliche Merkmale des Lichts werden in vier Unterthemen interpretiert Partizipative Ausstellung, in der die Zuschauer mit Kunstwerken interagieren Die Sektion

Infosys and Roland-Garros Empower Players, Fans and Media with New Digital Innovations on Court and at Home

Paris (ots/PRNewswire) - Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, and the French Tennis Federation, today announced the latest innovations set to hit the courts at this year's Roland-Garros, as part of the second year of the strategic technology partnership. Leveraging Infosys' technology platform, this year's tournament will deliver a digitally enhanced experience by facilitating virtual experiences and greater access for millions of fans, better training, and analysis

Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020

Darmstadt, Germany (ots/PRNewswire) - · New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer · Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib? from largest ongoing study in NSCLC harboring METex14 skipping · Long-term follow-up data for novel bifunctional fusion protein targeting TGF-?/PD-L1, bintrafusp alfa?, in NSCLC and BTC demonstrate continued

New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety

Darmstadt, Germany (ots/PRNewswire) - In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data from MAVENCLAD-treated patients with confirmed or suspected COVID-19 suggest no increased risk of severe outcomes Merck, a leading science and technology company, today announced the

Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis

Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Company to present 54 abstracts across its MS portfolio -MAVENCLAD® (cladribine tablets), Rebif® (interferon beta-1a) and investigational evobrutinib - New long-term data and real-world evidence further characterise efficacy and safety of MAVENCLAD® - New MAVENCLAD® and Rebif® safety data to be shared demonstrating no increased risk of respiratory viral infections Merck, a leading science and technology company, today announced it will

EANS-News: Resistant to coronaviruses: Semperit protective glove brings professional safety to Austrian households

Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. New Products/Company Information Vienna/Austria - * High-quality protective glove from Austria available in retail stores for the first time * Market launch with BIPA in early September * Production at the only European production facility for surgical gloves in Wimpassing, Lower Austria 2 September 2020 - The protective gloves of the Austrian Semperit Group, which

EANS-News: Strabag: Official contract start of A49 PPP motorway project in Hesse

Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. Government Contracts Vienna - European-based construction technology group STRABAG SE, through its subsidiary STRABAG Infrastrukturprojekt GmbH, has been awarded the contract for a large motorway project in Germany under a public-private partnership (PPP) model. Besides the construction of a 31 km long section of the A49 motorway between Schwalmstadt and the Ohmtal

OneWeb Announces HMG and Bharti Global Limited Consortium as Winning Bidders in Court-supervised Sale Process

London (ots/PRNewswire) - - A consortium of Her Majesty's Government (HMG) (through the UK Secretary of State for Business, Energy and Industrial Strategy) and Bharti Global Limited have committed to provide more than USD$1 billion to acquire OneWeb and fund the full restart of its business operations. - OneWeb will look to resume operations as soon as possible and continue with progress towards providing global high-speed, low latency connectivity via its state-of-the-art satellite constellation. - Agreement remains

Mental Health Care Company COMPASS Pathways Strengthens Leadership Team With Appointment of Trevor Mill as Chief Development Officer

London (ots/PRNewswire) - - Piers Morgan appointed earlier in the year as Chief Financial Officer and Gary Gilmour as Director of Preclinical Research COMPASS Pathways, a mental health care company, announced today that it has made a number of new appointments to its leadership team. Trevor Mill joins the company as Chief Development Officer with responsibility for research and development, including COMPASS's clinical development of psilocybin therapy for treatment-resistant depression. Earlier in the year, Piers